SLDE vs UPC

For growth investors, Slide Insurance Holdings, Inc.

Common Stock (SLDE) is the stronger pick with 36. 5% revenue growth year-over-year, versus -22. 4% for Universe Pharmaceuticals Inc. (UPC). Slide Insurance Holdings, Inc. Common Stock (SLDE) offers the better valuation at 5. 6x trailing P/E (5. 3x forward), making it the more compelling value choice. Analysts rate Slide Insurance Holdings, Inc. Common Stock (SLDE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Slide Insurance Holdings, Inc.

Common Stock (SLDE) delivered a total return of -6. 8%, compared to -100. 0% for Universe Pharmaceuticals Inc. (UPC). Over 10 years, the gap is even starker: SLDE returned -6. 8% versus UPC's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Slide Insurance Holdings, Inc.

Common Stock (SLDE) is the lower-risk stock at 0. 59β versus Universe Pharmaceuticals Inc. 's 1. 26β — meaning UPC is approximately 115% more volatile than SLDE relative to the S&P 500.

By revenue growth (latest reported year), Slide Insurance Holdings, Inc.

Common Stock (SLDE) is pulling ahead at 36. 5% versus -22. 4% for Universe Pharmaceuticals Inc. (UPC). On earnings-per-share growth, the picture is similar: Slide Insurance Holdings, Inc. Common Stock grew EPS 108. 7% year-over-year, compared to 26. 5% for Universe Pharmaceuticals Inc.. Over a 3-year CAGR, SLDE leads at 68. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Slide Insurance Holdings, Inc.

Common Stock (SLDE) is the more profitable company, earning 38. 4% net margin versus -20. 6% for Universe Pharmaceuticals Inc. — meaning it keeps 38. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SLDE leads at 51. 0% versus -16. 3% for UPC. At the gross margin level — before operating expenses — SLDE leads at 79. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Slide Insurance Holdings, Inc.

Common Stock (SLDE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 59)). Both have compounded well over 10 years (SLDE: -6. 8%, UPC: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SLDE (Financial Services) and UPC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SLDE is a small-cap high-growth stock; UPC is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.